{
  "type": "hyp",
  "text": "Patients had significantly poorer prognosis relative to patients treated with IR or TEMF had significantly poorer prognosis relative to patients treated with IL-2/IFN alpha-based therapy.\n",
  "self": {
    "NER": {
      "answers": [
        "TEMF",
        "IL-2"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "Patients treated with IR or what other therapy had a significantly lower prognosis?",
          "What is the name of the IL-2 based therapy?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Patients",
        "significantly poorer prognosis",
        "patients",
        "IR",
        "TEMF",
        "significantly poorer prognosis",
        "patients",
        "IL-2/IFN alpha-based therapy"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What group of patients had a significantly worse prognosis than those treated with IR",
          "What was the effect of IR on patients?",
          "What group of patients had a significantly worse prognosis than those treated with IR",
          "Patients treated with TEMF or IL-2 had a significantly poorer prognos",
          "Patients treated with IR or what other therapy had a significantly lower prognosis?",
          "What was the effect of IR on patients?",
          "What group of patients had a significantly worse prognosis than those treated with IR",
          "What treatment did patients with IR or TEMF receive?"
        ]
      }
    }
  },
  "asked": {
    "What is the name of the disease that is a chronic condition?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0009377598762512207,
        "ground_truth": {
          "CSC": {
            "bertscore": 0.697609007358551,
            "f1": 0
          }
        }
      }
    },
    "What treatment is used to treat CSC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.09147071838378906,
        "ground_truth": {
          "Photodynamic Therapy": {
            "bertscore": 0.6186999678611755,
            "f1": 0
          }
        }
      }
    },
    "Who is included in this report?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.11464804410934448,
        "ground_truth": {
          "Patients": {
            "bertscore": 0.6566063761711121,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the disease that is diagnosed with Photodynamic Therapy?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0027094483375549316,
        "ground_truth": {
          "chronic CSC": {
            "bertscore": 0.6566246151924133,
            "f1": 0
          }
        }
      }
    },
    "What is needed to diagnose CSC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00047147274017333984,
        "ground_truth": {
          "clinical evidence": {
            "bertscore": 0.6880121827125549,
            "f1": 0
          }
        }
      }
    },
    "What is the clinical evidence of CSC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0012340545654296875,
        "ground_truth": {
          "activity": {
            "bertscore": 0.6991472244262695,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the report that includes patients diagnosed with CSC and treated with Photodynamic": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0026369690895080566,
        "ground_truth": {
          "this report": {
            "bertscore": 0.6599560976028442,
            "f1": 0
          }
        }
      }
    }
  }
}